S&P 500   4,330.25 (+0.24%)
DOW   33,958.70 (-0.02%)
QQQ   358.31 (+0.11%)
AAPL   175.47 (+0.39%)
MSFT   316.59 (-0.13%)
META   300.00 (+0.31%)
GOOGL   130.80 (+0.42%)
AMZN   131.27 (+1.67%)
TSLA   245.74 (+0.35%)
NVDA   419.36 (+0.78%)
NIO   8.35 (-2.11%)
BABA   87.03 (-1.44%)
AMD   96.98 (+0.81%)
T   15.07 (-0.33%)
F   12.56 (+1.05%)
MU   68.35 (-0.77%)
CGC   0.93 (+10.43%)
GE   111.57 (+0.29%)
DIS   80.83 (-0.52%)
AMC   8.19 (+7.48%)
PFE   32.85 (+0.49%)
PYPL   58.80 (+1.59%)
NFLX   384.08 (+1.12%)
S&P 500   4,330.25 (+0.24%)
DOW   33,958.70 (-0.02%)
QQQ   358.31 (+0.11%)
AAPL   175.47 (+0.39%)
MSFT   316.59 (-0.13%)
META   300.00 (+0.31%)
GOOGL   130.80 (+0.42%)
AMZN   131.27 (+1.67%)
TSLA   245.74 (+0.35%)
NVDA   419.36 (+0.78%)
NIO   8.35 (-2.11%)
BABA   87.03 (-1.44%)
AMD   96.98 (+0.81%)
T   15.07 (-0.33%)
F   12.56 (+1.05%)
MU   68.35 (-0.77%)
CGC   0.93 (+10.43%)
GE   111.57 (+0.29%)
DIS   80.83 (-0.52%)
AMC   8.19 (+7.48%)
PFE   32.85 (+0.49%)
PYPL   58.80 (+1.59%)
NFLX   384.08 (+1.12%)
S&P 500   4,330.25 (+0.24%)
DOW   33,958.70 (-0.02%)
QQQ   358.31 (+0.11%)
AAPL   175.47 (+0.39%)
MSFT   316.59 (-0.13%)
META   300.00 (+0.31%)
GOOGL   130.80 (+0.42%)
AMZN   131.27 (+1.67%)
TSLA   245.74 (+0.35%)
NVDA   419.36 (+0.78%)
NIO   8.35 (-2.11%)
BABA   87.03 (-1.44%)
AMD   96.98 (+0.81%)
T   15.07 (-0.33%)
F   12.56 (+1.05%)
MU   68.35 (-0.77%)
CGC   0.93 (+10.43%)
GE   111.57 (+0.29%)
DIS   80.83 (-0.52%)
AMC   8.19 (+7.48%)
PFE   32.85 (+0.49%)
PYPL   58.80 (+1.59%)
NFLX   384.08 (+1.12%)
S&P 500   4,330.25 (+0.24%)
DOW   33,958.70 (-0.02%)
QQQ   358.31 (+0.11%)
AAPL   175.47 (+0.39%)
MSFT   316.59 (-0.13%)
META   300.00 (+0.31%)
GOOGL   130.80 (+0.42%)
AMZN   131.27 (+1.67%)
TSLA   245.74 (+0.35%)
NVDA   419.36 (+0.78%)
NIO   8.35 (-2.11%)
BABA   87.03 (-1.44%)
AMD   96.98 (+0.81%)
T   15.07 (-0.33%)
F   12.56 (+1.05%)
MU   68.35 (-0.77%)
CGC   0.93 (+10.43%)
GE   111.57 (+0.29%)
DIS   80.83 (-0.52%)
AMC   8.19 (+7.48%)
PFE   32.85 (+0.49%)
PYPL   58.80 (+1.59%)
NFLX   384.08 (+1.12%)
OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Forecast, Price & News

$2.09
-0.01 (-0.48%)
(As of 09/22/2023 08:53 PM ET)
Compare
Today's Range
$1.96
▼
$2.14
50-Day Range
$1.02
▼
$2.68
52-Week Range
$1.00
▼
$4.20
Volume
303,800 shs
Average Volume
699,712 shs
Market Capitalization
$722.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.05
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest

Cresco Labs MarketRank™ Forecast

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
667.9% Upside
$16.05 Price Target
Short Interest
Healthy
0.42% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.06mentions of Cresco Labs in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.21) to ($0.09) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CRLBF stock logo

About Cresco Labs (OTCMKTS:CRLBF) Stock

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Price History

CRLBF Stock News Headlines

September 24, 2023 | americanbankingnews.com
Bright Green (NASDAQ:BGXX) and Cresco Labs (OTCMKTS:CRLBF) Critical Review
September 21, 2023 | finance.yahoo.com
Cresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower Products
September 25, 2023 | UNKNOWN (Ad)
Top Wellness Nasdaq Stock for 2023
Cutting-Edge Ai-Based Technology Is Set to Disrupt the Womens Wellness Space
September 19, 2023 | americanbankingnews.com
Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Average Rating of "Hold" from Brokerages
September 16, 2023 | msn.com
Cresco marijuana facility in Wawarsing has yet to create first 75 promised jobs, but maintains a commitment to the project
September 13, 2023 | msn.com
Why Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank Today
September 12, 2023 | markets.businessinsider.com
Cresco Labs Takes On Trulieve As Major Competitor In Florida Where Weed Market Is Poised To Explode
September 12, 2023 | finance.yahoo.com
Cresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store Nationwide
September 25, 2023 | UNKNOWN (Ad)
Top Wellness Nasdaq Stock for 2023
Cutting-Edge Ai-Based Technology Is Set to Disrupt the Womens Wellness Space
September 7, 2023 | markets.businessinsider.com
Weed Ads On Spotify? This Cannabis Giant Makes It Happen Via New Partnership
September 7, 2023 | finance.yahoo.com
Cresco Labs Launches First-Ever Cannabis Advertisements on Spotify, the World’s Most Popular Audio Streaming Subscription Service
September 5, 2023 | msn.com
Why Cresco Labs Stock Wafted Nearly 5% Higher Today
September 5, 2023 | benzinga.com
EXCLUSIVE: How Federal Cannabis Reclassification Could Transform Business Finances, Insights From Cresco Labs' CEO
August 18, 2023 | benzinga.com
Cresco Labs And Temple University Join Forces To Research The Untapped Medical Benefits Of Cannabis
August 17, 2023 | markets.businessinsider.com
Analysts Offer Insights on NA Companies: Cresco Labs (OtherCRLBF) and TJX Companies (TJX)
August 16, 2023 | msn.com
Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Tops Revenue Estimates
August 16, 2023 | msn.com
Why Marijuana Stock Cresco Labs Jumped Today
August 16, 2023 | bizjournals.com
Cresco Labs retains No. 1 market share on cannabis products in Illinois
August 16, 2023 | seekingalpha.com
Cresco Labs reports Q2 results
August 16, 2023 | markets.businessinsider.com
Analysts Offer Insights on NA Companies: Cresco Labs (OtherCRLBF) and Target (TGT)
August 16, 2023 | markets.businessinsider.com
Cresco Labs Reports Slight Sequential Improvement In Q2, YoY Drop In Revenue And Gross Profit As Net Loss Grows
August 16, 2023 | finance.yahoo.com
Cresco Labs Reports Second Quarter 2023 Results
August 15, 2023 | benzinga.com
Earnings Outlook For Cresco Labs
August 15, 2023 | msn.com
Which Cannabis Stocks Are Best in 2023? We Name the Top 3
August 10, 2023 | msn.com
Will Cresco Labs Inc. (CRLBF) Report Negative Q2 Earnings? What You Should Know
August 7, 2023 | markets.businessinsider.com
Cresco Labs Opens Its 69th Cannabis Dispensary
August 7, 2023 | finance.yahoo.com
Cresco Labs Expands Sunnyside in East Central Florida with New Store in Palm Bay
See More Headlines
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Company Calendar

Last Earnings
8/16/2023
Today
9/25/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CRLBF
CUSIP
N/A
CIK
1832928
Web
www.crescolabs.com
Phone
312-929-0993
Fax
N/A
Employees
3,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.05
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+667.9%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-212,050,000.00
Net Margins
-29.14%
Pretax Margin
-22.68%
Return on Equity
-9.52%
Return on Assets
-3.68%

Debt

Debt-to-Equity Ratio
1.14
Current Ratio
1.12
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$842.68 million
Price / Sales
0.86
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.70 per share
Price / Book
1.23

Miscellaneous

Outstanding Shares
345,620,000
Free Float
N/A
Market Cap
$722.35 million
Optionable
Not Optionable
Beta
2.52
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Thomas J. Manning (Age 67)
    Exec. Chairman
    Comp: $800.05k
  • Mr. Charles Bachtell (Age 44)
    Co-Founder, CEO & Director
    Comp: $999.85k
  • Mr. Robert M. Sampson (Age 48)
    Co-Founder & Independent Director
  • Mr. Dennis M. Olis (Age 60)
    Chief Financial Officer
    Comp: $622.85k
  • Mr. Ty Gent (Age 64)
    Chief Operating Officer
  • Ms. Brenna Albert CPA
    Sr. VP and Controller of Accounting, Treasury & Tax
  • Mr. Zach Marburger (Age 38)
    Chief Information Officer
  • Jake Graves
    Mang. of Investor Relations
  • Mr. John Schetz (Age 45)
    Gen. Counsel
  • Mr. Jason Erkes (Age 52)
    Chief Communications Officer

Key Competitors

View All Competitors













CRLBF Stock - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares.
View CRLBF analyst ratings or view top-rated stocks.

What is Cresco Labs' stock price forecast for 2023?

8 equities research analysts have issued 1-year price targets for Cresco Labs' shares. Their CRLBF share price forecasts range from $2.50 to $34.00. On average, they anticipate the company's stock price to reach $16.05 in the next year. This suggests a possible upside of 667.9% from the stock's current price.
View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts.

How have CRLBF shares performed in 2023?

Cresco Labs' stock was trading at $1.80 on January 1st, 2023. Since then, CRLBF shares have increased by 16.1% and is now trading at $2.09.
View the best growth stocks for 2023 here.

Are investors shorting Cresco Labs?

Cresco Labs saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,447,200 shares, an increase of 15.4% from the August 15th total of 1,254,400 shares. Based on an average daily trading volume, of 1,565,500 shares, the days-to-cover ratio is presently 0.9 days.
View Cresco Labs' Short Interest.

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) announced its quarterly earnings data on Wednesday, August, 16th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.02. The business earned $197.89 million during the quarter, compared to the consensus estimate of $194.60 million. Cresco Labs had a negative trailing twelve-month return on equity of 9.52% and a negative net margin of 29.14%.

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $2.09.

How much money does Cresco Labs make?

Cresco Labs (OTCMKTS:CRLBF) has a market capitalization of $722.35 million and generates $842.68 million in revenue each year. The company earns $-212,050,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Cresco Labs have?

The company employs 3,200 workers across the globe.

How can I contact Cresco Labs?

Cresco Labs' mailing address is 400 West Erie Street, Chicago, IL 60654. The official website for the company is www.crescolabs.com. The company can be reached via phone at 312-929-0993 or via email at investors@crescolabs.com.

This page (OTCMKTS:CRLBF) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -